Pargyline is an irreversible (covalent) selective monoamine oxidase (MAO)-B inhibitor drugwith antihypertensive properties. Pargyline has been found to bind with high affinity to the I2 imidazoline receptor (an allosteric site on the MAO enzyme). References: Bazzu G, Rocchitta G, Migheli R, Alvau MD, Zinellu M, Puggioni G, Calia G, Mercanti G, Giusti P, Desole MS, Serra PA. Effects of the neurotoxin MPTP and pargyline protection on extracellular energy metabolites and dopamine levels in the striatum of freely moving rats. Brain Res. 2013 Nov 13;1538:159-71. doi: 10.1016/j.brainres.2013.09.037. Epub 2013 Sep 27. PubMed PMID: 24080403.

纯度：≥98%

CAS：555-57-7